These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 22126467
1. Histological type of intrahepatic cholangiocarcinoma differentiated by genetic alteration from AP-PCR fingerprint. Chuensumran U, Saelee P, Wongkham S, Pairojkul C, Chauin S, Petmitr S. Asian Pac J Cancer Prev; 2011; 12(6):1377-80. PubMed ID: 22126467 [Abstract] [Full Text] [Related]
3. Ubiquitin-specific protease 14 expression associated with intrahepatic cholangiocarcinoma cell differentiation. Chuensumran U, Saelee P, Punyarit P, Wongkham S, Pairojkul C, Chauin S, Petmitr S. Asian Pac J Cancer Prev; 2011; 12(3):775-9. PubMed ID: 21627382 [Abstract] [Full Text] [Related]
4. Novel DNA amplification on chromosomes 2p25.3 and 7q11.23 in cholangiocarcinoma identified by arbitrarily primed polymerase chain reaction. Chariyalertsak S, Khuhaprema T, Bhudisawasdi V, Sripa B, Wongkham S, Petmitr S. J Cancer Res Clin Oncol; 2005 Dec; 131(12):821-8. PubMed ID: 16180024 [Abstract] [Full Text] [Related]
5. Genome wide DNA copy number analysis in cholangiocarcinoma using high resolution molecular inversion probe single nucleotide polymorphism assay. Arnold A, Bahra M, Lenze D, Bradtmöller M, Guse K, Gehlhaar C, Bläker H, Heppner FL, Koch A. Exp Mol Pathol; 2015 Oct; 99(2):344-53. PubMed ID: 26260902 [Abstract] [Full Text] [Related]
8. The pathways of genetic transformation in cholangiocarcinogenesis. Serafini FM, Radvinsky D. Cancer Genet; 2016 Dec; 209(12):554-558. PubMed ID: 27720541 [Abstract] [Full Text] [Related]
9. Prognostic value of DNA alterations on chromosome 17p13.2 for intrahepatic cholangiocarcinoma. Chuensumran U, Wongkham S, Pairojkul C, Chauin S, Petmitr S. World J Gastroenterol; 2007 Jun 07; 13(21):2986-91. PubMed ID: 17589952 [Abstract] [Full Text] [Related]
10. Intrahepatic cholangiocarcinoma with lymphoepithelioma-like component. Chen TC, Ng KF, Kuo T. Mod Pathol; 2001 May 07; 14(5):527-32. PubMed ID: 11353065 [Abstract] [Full Text] [Related]
11. Mutation of p53 and K-ras, and loss of heterozygosity of APC in intrahepatic cholangiocarcinoma. Kang YK, Kim WH, Lee HW, Lee HK, Kim YI. Lab Invest; 1999 Apr 07; 79(4):477-83. PubMed ID: 10212000 [Abstract] [Full Text] [Related]
12. Genetic alterations in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Koo SH, Ihm CH, Kwon KC, Park JW, Kim JM, Kong G. Cancer Genet Cytogenet; 2001 Oct 01; 130(1):22-8. PubMed ID: 11672769 [Abstract] [Full Text] [Related]
13. Allelotype analysis of intrahepatic cholangiocarcinoma. Kang YK, Kim YI, Kim WH. Mod Pathol; 2000 Jun 01; 13(6):627-31. PubMed ID: 10874666 [Abstract] [Full Text] [Related]
17. Defining the biology of intrahepatic cholangiocarcinoma: molecular pathways and early detection of precursor lesions. Gibiino G, Fabbri C, Fagiuoli S, Ianiro G, Fornelli A, Cennamo V. Eur Rev Med Pharmacol Sci; 2017 Feb 01; 21(4):730-741. PubMed ID: 28272710 [Abstract] [Full Text] [Related]
18. Biliary dysplasia in primary sclerosing cholangitis harbors cytogenetic abnormalities similar to cholangiocarcinoma. Kerr SE, Barr Fritcher EG, Campion MB, Voss JS, Kipp BR, Halling KC, Lewis JT. Hum Pathol; 2014 Sep 01; 45(9):1797-804. PubMed ID: 25027853 [Abstract] [Full Text] [Related]